Denise Evans1, Mhairi Maskew, Ian Sanne. 1. Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. devans@witshealth.co.za
Abstract
OBJECTIVE: We investigated the effect of oropharyngeal candidiasis (OC) and body mass index (BMI) before antiretroviral therapy (ART) initiation on treatment outcomes of human immunodeficiency virus (HIV)-positive patients. STUDY DESIGN: Treatment outcomes included failure to increase CD4 count by ≥50 or ≥100 cells/μL or failure to suppress viral load (<400 copies/mL) at 6 or 12 months in addition to loss to follow-up (LTFU) and mortality by 12 months. Risk and hazard ratios (HRs) were estimated with the use of log-binomial regression and Cox proportional hazards models, respectively. RESULTS: Baseline CD4 <100 cells/μL, low BMI (<18.5 kg/m(2)), low hemoglobin, and elevated aspartate transaminase were associated with OC at ART initiation. Patients with low BMI with and without, respectively, OC were at risk of mortality (HR 2.42, 95% CI 1.88-3.12; HR 1.87, 95% CI 1.54-2.28) and LTFU (HR 1.36, 95% CI 1.02-1.82; HR 1.55, 95% CI 1.30-1.85). CONCLUSIONS: Low BMI (with/without OC) at ART initiation was associated with poor treatment outcomes. Conversely, normal BMI with OC was associated with adequate CD4 response and reduced LTFU compared with without OC.
OBJECTIVE: We investigated the effect of oropharyngeal candidiasis (OC) and body mass index (BMI) before antiretroviral therapy (ART) initiation on treatment outcomes of humanimmunodeficiency virus (HIV)-positivepatients. STUDY DESIGN: Treatment outcomes included failure to increase CD4 count by ≥50 or ≥100 cells/μL or failure to suppress viral load (<400 copies/mL) at 6 or 12 months in addition to loss to follow-up (LTFU) and mortality by 12 months. Risk and hazard ratios (HRs) were estimated with the use of log-binomial regression and Cox proportional hazards models, respectively. RESULTS: Baseline CD4 <100 cells/μL, low BMI (<18.5 kg/m(2)), low hemoglobin, and elevated aspartate transaminase were associated with OC at ART initiation. Patients with low BMI with and without, respectively, OC were at risk of mortality (HR 2.42, 95% CI 1.88-3.12; HR 1.87, 95% CI 1.54-2.28) and LTFU (HR 1.36, 95% CI 1.02-1.82; HR 1.55, 95% CI 1.30-1.85). CONCLUSIONS: Low BMI (with/without OC) at ART initiation was associated with poor treatment outcomes. Conversely, normal BMI with OC was associated with adequate CD4 response and reduced LTFU compared with without OC.
Authors: J R Arribas; S Hernández-Albujar; J J González-García; J M Peña; A Gonzalez; T Cañedo; R Madero; J J Vazquez; W G Powderly Journal: AIDS Date: 2000-05-26 Impact factor: 4.177
Authors: Velia Ramírez-Amador; Gabriela Anaya-Saavedra; Juan J Calva; Tirso Clemades-Pérez-de-Corcho; Carlos López-Martínez; Imelda González-Ramírez; Juan Sierra-Madero Journal: Arch Med Res Date: 2006-07 Impact factor: 2.235
Authors: Andrew Boulle; Gilles Van Cutsem; Katherine Hilderbrand; Carol Cragg; Musaed Abrahams; Shaheed Mathee; Nathan Ford; Louise Knight; Meg Osler; Jonny Myers; Eric Goemaere; David Coetzee; Gary Maartens Journal: AIDS Date: 2010-02-20 Impact factor: 4.177
Authors: C P Lindan; S Allen; A Serufilira; A R Lifson; P Van de Perre; A Chen-Rundle; J Batungwanayo; F Nsengumuremyi; J Bogaerts; S Hulley Journal: Ann Intern Med Date: 1992-02-15 Impact factor: 25.391
Authors: Sarah W Beckham; Chris Beyrer; Peter Luckow; Meg Doherty; Eyerusalem K Negussie; Stefan D Baral Journal: J Int AIDS Soc Date: 2016-11-08 Impact factor: 5.396
Authors: Rachel A Silverman; Grace C John-Stewart; Ingrid A Beck; Ross Milne; Catherine Kiptinness; Christine J McGrath; Barbra A Richardson; Bhavna Chohan; Samah R Sakr; Lisa M Frenkel; Michael H Chung Journal: PLoS One Date: 2019-10-04 Impact factor: 3.240
Authors: Samantha Kaplan; Katleho S Nteso; Nathan Ford; Andrew Boulle; Graeme Meintjes Journal: South Afr J HIV Med Date: 2019-12-18 Impact factor: 2.744